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Abstract
Hepatic fat deposition with hepatocellular damage, a feature of non-alcoholic fatty liver disease, is mediated by several
putative factors including prostaglandins. In the present study, we examined whether group IVA phospholipase A2 (IVA-
PLA2), which catalyzes the first step in prostanoid biosynthesis, is involved in the development of fatty liver, using IVA-PLA2-
knockout mice. Male wild-type mice on high-fat diets (20% fat and 1.25% cholesterol) developed hepatocellular vacuolation
and liver hypertrophy with an increase in the serum levels of liver damage marker aminotransferases when compared with
wild-type mice fed normal diets. These high-fat diet-induced alterations were markedly decreased in IVA-PLA2-knockout
mice. Hepatic triacylglycerol content was lower in IVA-PLA2-knockout mice than in wild-type mice under normal dietary
conditions. Although high-fat diets increased hepatic triacylglycerol content in both genotypes, the degree was lower in
IVA-PLA2-knockout mice than in wild-type mice. Under the high-fat dietary conditions, IVA-PLA2-knockout mice had lower
epididymal fat pad weight and smaller adipocytes than wild-type mice. The serum level of prostaglandin E2, which has a fat
storage effect, was lower in IVA-PLA2-knockout mice than in wild-type mice, irrespective of the kind of diet. In both
genotypes, high-fat diets increased serum leptin levels equally between the two groups, but did not affect the serum levels
of adiponectin, resistin, free fatty acid, triacylglycerol, glucose, or insulin. Our findings suggest that a deficiency of IVA-PLA2
alleviates fatty liver damage caused by high-fat diets, probably because of the lower generation of IVA-PLA2 metabolites,
such as prostaglandin E2. IVA-PLA2 could be a promising therapeutic target for obesity-related diseases including non-
alcoholic fatty liver disease.
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Introduction
Phospholipase A2 (PLA2) is an enzyme that catalyzes the
hydrolysis of glycerophospholipids at the sn-2 position, generating
free fatty acid (FFA) and lysophospholipid. Among the more than
twenty isozymes of mammalian PLA2, group IVA PLA2 (IVA-
PLA2) is a key enzyme responsible for the release of arachidonic
acid, a precursor of prostaglandins (PGs) [1]. Our recent study of
IVA-PLA2-knockout mice fed normal chow diets demonstrated
that decreases in hepatic triacylglycerol (TG) content and the size
of epididymal adipocytes are observed with a lower serum level of
PGE2 compared with wild-type mice. This suggests that the
circulating level of PGE2 is related to the levels of intracellular TG
in the liver and adipose tissues [2]. Previous reports showed that
the stimulation of rat hepatocytes with PGE2 and the administra-
tion of PGE2 to rats induce increases in TG level in the cells and
the liver, respectively [3,4]. Similarly, 15-deoxy-PGJ2 endoge-
nously generated in mature 3T3-L1 adipocytes has been shown to
be responsible for the storage of TG [5]. Considering these
findings, it is possible that IVA-PLA2 mediates fat deposition in the
liver and adipose tissues through the generation of PGs.
The accumulationof hepatic TG is a major symptom of alcoholic
liver disease. However, hepatic fat deposition resulting from TG
accumulation has also been found in the absence of alcohol abuse.
Such fatty liver progresses to non-alcoholic fatty liver disease
(NAFLD) followed by the development of non-alcoholic steatohe-
patitis and cirrhosis [6]. NAFLD is closely associated with
abdominal obesity, a feature of metabolic syndrome [7]. Obesity
from overeating high-fat (HF) and/or high-caloric foods is
characterized by an abnormal increase in adipose tissue mass
mainlyresulting from the excessive storageofTG withinadipocytes.
The state of obesity is accompanied by changes in the expression
and secretion of adipokines including adiponectin and resistin, and
by an increased release of FFA from hypertrophied adipocytes. The
alterations in the circulating levels of adipokines and FFA are
involved in the accumulation of TG causing liver damage [6,8].
Consequently, factors that modulate intracellular TG levels and/or
circulating adipokine levels could be targets for the prevention of
fatty liver and the development of NAFLD. Considering our recent
finding that hepatic TG content is lower in IVA-PLA2-knockout
mice fed normal chow diets than in wild-type mice [2], it is possible
that a suppression of IVA-PLA2 protects against the development of
fatty liver under HF dietary conditions.
Taking this into account, in the present study, we examined the
possible involvement of IVA-PLA2 in the development of fatty
liver using IVA-PLA2-knockout mice fed HF diets. The current
PLoS ONE | www.plosone.org 1 December 2009 | Volume 4 | Issue 12 | e8089study demonstrated that a deficiency of IVA-PLA2 protected mice
against HF diet-induced increases in the number of hepatocytes
exhibiting cytoplasmic vacuolation and hepatic TG content
accompanying liver damage. These findings and further results
shown here suggest that IVA-PLA2 is involved in the development
of fatty liver damage under HF dietary conditions.
Results
Microscopic views of the liver of wild-type and IVA-PLA2-
knockout mice fed normal or HF diets for 8 or 16 weeks are shown
in Figure 1. The results reveal an apparent cytoplasmic
vacuolation of hepatocytes around the central vein in wild-type
mice fed HF diets for 8 (Figure 1A) or 16 (Figure 1B) weeks
compared with wild-type mice fed normal diets for 8 (Figure 1A)
or 16 weeks (data not shown). The degree of hepatic vacuolation
increased with the period of feeding. In wild-type mice fed HF
diets for 16 weeks, a markedly high level of cytoplasmic
vacuolation of hepatocytes around the portal vein was observed
compared with that in cells around the central vein (Figure 1B).
The vacuolated area was not stained with periodic acid-Schiff,
which stains glycogen (data not shown). In contrast to wild-type
mice fed HF diets, we found that cytoplasmic vacuolation of
hepatocytes around the central and portal veins was strikingly
suppressed in IVA-PLA2-knockout mice fed HF diets for 8 weeks
(Figure 1A). Even after 16 weeks of HF feeding, IVA-PLA2-
knockout mice exhibited considerably reduced hepatic vacuolation
(Figure 1B). Under normal dietary conditions, slight cytoplasmic
vacuolation was observed in hepatocytes of wild-type mice;
however, this was not the case for IVA-PLA2-knockout mice
(Figure 1A). This observation in mice fed normal diets was
consistent with the results shown in our recent paper [2].
The histological results shown in Figure 1 suggest that a
deficiency of IVA-PLA2 decreases HF diet-induced fat deposition
in the liver, leading us to measure hepatic TG content under HF
dietary conditions. Consistent with the histological results, hepatic
TG content was apparently greater in wild-type mice fed HF diets
for 8 weeks than in wild-type mice fed normal diets, as shown in
Figure 2. In IVA-PLA2-knockout mice fed normal diets, hepatic
TG content was lower than that in wild-type mice, as reported in
our recent paper [2]. Although HF diets also increased hepatic TG
content in IVA-PLA2-knockout mice, the level was significantly
lower than that in HF diet-fed wild-type mice, and almost at the
level found in normal diet-fed wild-type mice. The degree of the
HF diet-induced increase in hepatic TG content was lower in
IVA-PLA2-knockout mice than in wild-type mice.
As shown in Table 1, the weights of the body, liver, and
epidermal fat pads increased in wild-type mice fed HF diets for 8
or 16 weeks compared with respective wild-type mice fed normal
diets. While no significant difference in these weights was observed
between IVA-PLA2-knockout mice fed normal and HF diets for 8
weeks, HF feeding for 16 weeks increased these weights. However,
these weights in IVA-PLA2-knockout mice fed HF diets were lower
than those in wild-type mice fed HF diets. Under the dietary
conditions, there was no significant difference in the amounts of
food intake between the two genotype mice fed HF diets for 16
weeks (wild-type, 2.7760.18 g/day; IVA-PLA2-knockout,
2.9060.27 g/day, n=5), or between those fed normal diets for
16 weeks (wild-type, 3.6860.18 g/day; IVA-PLA2-knockout,
3.8960.10 g/day, n=7). Consistent with the change in liver
weights, macroscopic views of the liver revealed visible hypertro-
phy in wild-type mice fed HF diets for 16 weeks compared with
wild-type mice fed normal diets, as shown in Figure 3. However,
such hypertrophy was suppressed in IVA-PLA2-knockout mice fed
HF diets (Figure 3). Furthermore, the epididymal fat pads were
visibly smaller in IVA-PLA2-knockout mice fed HF diets than in
wild-type mice (data not shown). Similarly, as shown in Figure 4,
microscopic views of epididymal fat pads revealed that the
adipocytes of epididymal fat pads were larger in wild-type mice
fed HF diets for 8 weeks than in wild-type mice fed normal diets.
Although HF diets also increased adipocyte size in IVA-PLA2-
knockout mice, the adipocytes under the HF dietary conditions
were smaller in IVA-PLA2-knockout mice than in wild-type mice
(Figure 4). Similar results were observed after 16 weeks of HF
feeding (data not shown).
Under the dietary conditions where HF diets taken for 8 weeks
induced fat deposition in the liver and adipose tissues of wild-type
mice but not IVA-PLA2-knockout mice (Figures 1, 2, and 4), no
significantchangeinthe serumlevelsofTGwasobservedasfollows:
wild-type mice fed normal diets, 60.8 mg/dl63.6; wild-type mice
fed HF diets, 72.0 mg/dl63.5; IVA-PLA2-knockout mice fed
normal diets, 70.8 mg/dl63.3; IVA-PLA2-knockout mice fed HF
diets, 75.0 mg/dl615.5; n=3–5. Similar results were observed
after 16 weeks of feeding (data not shown). Furthermore, there was
no differencebetween the serum levels of FFAfor the two genotypes
(Table 1). HF diets taken for 8 weeks also did not affect the serum
level of glucose (wild-type mice fed normal diets, 135 mg/dl69;
wild-type mice fed HF diets, 118 mg/dl613; IVA-PLA2-knockout
mice fed normal diets, 122 mg/dl615; IVA-PLA2-knockout mice
fed HF diets, 111 mg/dl67; n=4–5). Under our experimental
conditions, there were no differences in the serum levels of insulin
after 8 weeks of HF feeding as follows: wild-type mice fed normal
diets, 0.84 ng/ml60.21; wild-type mice fed HF diets, 1.14 ng/
ml60.14; IVA-PLA2-knockout mice fed normal diets, 1.22 ng/
ml60.10; IVA-PLA2-knockout mice fed HF diets, 0.94 ng/
ml60.33; n=4–5. HF diets taken for 16 weeks also did not affect
the serum level of insulin (data not shown). In contrast, while no
significant change in the serum level of phospholipids or
lysophosphatidylcholine was observed in the two genotype mice
fedHFdietsfor8 weeks,HFdietstakenfor16weeksincreasedthese
serum levels in wild-type mice but not IVA-PLA2-knockout mice
(Table 1). Consistent with this, the profiles of lipoproteins shown in
Figure 5 reveal that wild-type mice fed HF diets for 16 weeks had
higher serum levels of low-density lipoprotein (LDL) and high-
density lipoprotein (HDL) than wild-type mice fed normal diets, but
a change in the serum level of very low-density lipoprotein (VLDL)
was scarcely observed. In IVA-PLA2-knockout mice fed HF diets,
the serum level of LDL but not HDL was reduced compared with
those in wild-type mice fed HF diets. Although TG content of these
lipoproteins was concomitantly measured, there was no difference
between thefourgroups(datanot shown).Furthermore,asshownin
Table 2, we confirmed that the serum level of PGE2 was
significantly lower in IVA-PLA2-knockout mice than in wild-type
mice under the dietary conditions.
The elevation of serum aminotransferase level, as a marker of
liver damage, is correlated with NAFLD [9]. In agreement with
this, we show here that the serum level of alanine aminotransferase
(ALT) was significantly higher in wild-type mice fed HF diets for 8
weeks than in wild-type mice fed normal diets, and the serum
levels of both ALT and aspartate aminotransferase (AST) were
markedly increased after 16 weeks of HF feeding (Table 1).
However, no elevation of these aminotransferase levels was
observed in IVA-PLA2-knockout mice even under HF dietary
conditions. Considering the correlation of hepatic fat deposition
with liver damage, it is likely that the protection against the HF
diet-induced elevation of serum aminotransferase levels in IVA-
PLA2-knockout mice is due to the reduced hepatic vacuolation
and TG content.
PLA2-Mediated Fatty Liver
PLoS ONE | www.plosone.org 2 December 2009 | Volume 4 | Issue 12 | e8089Figure 1. Microscopic views of the liver in wild-type and IVA-PLA2-knockout mice. Wild-type and IVA-PLA2-knockout (KO) mice were fed
normal (N) or high-fat (HF) diets for 8 (A) or 16 (B) weeks and fasted. Representative liver sections stained with hematoxylin-eosin are shown. IVA-PLA2
deficiency suppressed the hepatic fat deposition under the HF feeding. CV, central vein; PV, portal vein. Original magnification, 64 and 620.
doi:10.1371/journal.pone.0008089.g001
PLA2-Mediated Fatty Liver
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including adiponectin, leptin, and resistin influence the accumu-
lation of intracellular lipids in the liver [10,11]. Taking this into
account, we determined the serum levels of adipokines in wild-type
and IVA-PLA2-knockout mice fed normal or HF diets. As shown
in Figure 6A, HF diets taken for 8 weeks did not affect the serum
levels of adiponectin in wild-type and IVA-PLA2-knockout mice.
In contrast, HF diets increased the serum levels of leptin in both
genotypes, with no difference exhibited between the levels in the
two groups (Figure 6B). Furthermore, no significant difference was
observed in the serum levels of resistin among the four groups
under our experimental conditions (Figure 6C).
Discussion
Fatty liver with hepatocellular damage occurs in parallel with
the accumulation of hepatic TG, which is associated with
abdominal obesity. The present study showed that HF feeding
of wild-type mice increased hepatocellular vacuolation, hepatic
TG content, and serum aminotransferase levels with increases in
adipose tissue mass and the number of hypertrophic adipocytes,
Figure 2. Hepatic triacylglycerol content in wild-type and IVA-
PLA2-knockout mice. Wild-type and IVA-PLA2-knockout mice were
fed normal (N) or high-fat (HF) diets for 8 weeks and fasted.
Triacylglycerol content in the liver was measured (n=5–7). IVA-PLA2
deficiency suppressed the accumulation of hepatic triacylglycerol under
the HF feeding. *P,0.005 versus wild-type mice fed normal diets,
**P,0.05 versus wild-type mice fed normal diets, ***P,0.01 versus
wild-type mice fed HF diets.
doi:10.1371/journal.pone.0008089.g002
Table 1. Weights of the body, epidermal fat pads, and liver, and serum levels of biochemical parameters under high-fat dietary
conditions.
Body weight (g) Liver weight (g) Fat pad weight (g) FFA (mEq/l) PL (mg/dl) LPC (mM) ALT (U/l) AST (U/l)
8 weeks of feeding
WT (N) 23.161.3 1.160.1 0.460.1 0.860.1 235624 377626 4665.5 156624
WT (HF) 31.163.9
a 1.760.4 1.360.4
a 0.660.1 226635 455680 107625
a 157626
KO (N) 25.361.4 1.160.1 0.260.04 0.860.1 28867 4186639 3664.0 154631
KO (HF) 28.561.5 1.260.04 0.760.1 0.660.02 275621 478653 4064.9
b 138640
16 weeks of feeding
WT (N) 33.962 1.360.1 1.160.1 0.660.1 178622 407623 58619 165626
WT (HF) 40.860.7
a 2.660.4
a 2.060.1
a 0.660.1 361635
a 575633
a 350677
a 366671
a
KO (N) 25.261.1
c 1.460.1 0.460.03
c 0.860.1 173632 419618 104658 215610
KO (HF) 36.262.8 1.960.3 1.560.5 0.560.02 18868
b 411614
b 87621
b 134621
b
Wild-type (WT) and IVA-PLA2-knockout (KO) mice fed normal (N) or high-fat (HF) diets for 8 or 16 weeks were fasted and subjected to each measurement (n=4–6). FFA,
free fatty acid; PL, phospholipids; LPC, lysophosphatidylcholine; ALT, alanine aminotransferase; AST, aspartate aminotransferase.
aP,0.05 versus wild-type mice fed normal diets.
bP,0.05 versus wild-type mice fed HF diets.
cP,0.005 versus wild-type mice fed normal diets.
doi:10.1371/journal.pone.0008089.t001
Figure 3. Macroscopic views of the liver in wild-type and IVA-
PLA2-knockout mice. Wild-type (WT) and IVA-PLA2-knockout (KO)
mice were fed normal (N) or high-fat (HF) diets for 16 weeks and fasted.
Representative photographs of the liver in each mouse are shown. IVA-
PLA2 deficiency suppressed the hepatic hypertrophy induced by HF
feeding.
doi:10.1371/journal.pone.0008089.g003
PLA2-Mediated Fatty Liver
PLoS ONE | www.plosone.org 4 December 2009 | Volume 4 | Issue 12 | e8089indicating that HF diet-fed wild-type mice exhibited fatty liver
damage with adipose fat deposition. The amounts of hepatic and
adipose fats are regulated by several factors including FFA, insulin,
adipokines, and PGs. Among these factors, PGs are generated by
the cyclooxygenase pathway of the arachidonic acid cascade, the
first step of which is mainly catalyzed by IVA-PLA2 [1]. Previous
reports showed that PGE2 and 15-deoxy-PGJ2 accelerate the
deposition of fats in hepatocytes and adipocytes [3,5,12].
Furthermore, the administration of PGE2 to rats increases hepatic
TG content [4]. In addition to PGs, arachidonic acid metabolites
of the 12-lipoxygenase pathway, such as 12-hydroxyeicosatetrae-
noic acid, are suggested to mediate inflammation occurring with
fat deposition in adipose tissues [13]. Considering the role of IVA-
PLA2 in the arachidonic acid cascade, it is possible that hepatic fat
deposition could be ameliorated when the production of such
arachidonic acid metabolites is suppressed by the inhibition of
IVA-PLA2. Consistent with our expectations, the present study
clearly showed that in IVA-PLA2-knockout mice with lower serum
levels of PGE2, a lack of IVA-PLA2 alleviated the HF diet-induced
hepatic fat deposition with hepatocellular damage, and reduced
adipose accumulation. Our findings suggest that an inhibition of
IVA-PLA2 prevents the HF diet-induced development of fatty liver
damage. This notion is consistent with a recent observation that
the administration of a cyclooxygenase-2 inhibitor to HF diet-fed
rats prevents fat deposition in the liver and adipose tissues [14].
The present study further shows that HF diet-fed wild-type mice
exhibited fatty liver damage with higher serum levels of
phospholipids, lysophosphatidylcholine, and LDL. However, in
IVA-PLA2-knockout mice, a deficiency of IVA-PLA2 reduced the
HF diet-induced increase in these serum levels as well as fatty liver
damage. These findings seem to indicate that the suppressed
increase in LDL levels in IVA-PLA2-knockout mice fed HF diets
probably results from suppressing the HF diet-induced develop-
ment of fatty liver damage. In addition, the changes in the serum
levels of phospholipids and lysophosphatidylcholine may be
correlated with the serum levels of LDL.
Obesity with fat deposition in abdominal adipose tissues is
implicated in the accumulation of hepatic TG through an increased
influx of FFA into hepatocytes from hypertrophied adipocytes [7,8],
and/or through alterations of the secretion of adipokines including
adiponectin and resistin that regulate, respectively, fat burning and
fat storage in the liver [8,10,11,15]. However, under our
experimental conditions, wild-type mice on HF diets exhibited no
change in the serum levels of not only FFA, adiponectin, and
resistin,butalsoTG, glucose, or insulin, despite hepatic and adipose
fat deposition. Thus, HF diet-fed wild-type mice developed fatty
liver and adipose accumulation in the absence of significant features
Figure 5. Lipoprotein profiles under HF dietary conditions.
Wild-type (WT) and IVA-PLA2-knockout (KO) mice were fed normal or HF
diets for 16 weeks and fasted. The serum levels of VLDL, LDL, and HDL
were analyzed. Each trace represents the mean (n=4–6). IVA-PLA2
deficiency reduced the increased serum level of LDL by HF feeding.
doi:10.1371/journal.pone.0008089.g005
Table 2. Serum levels of PGE2 in wild-type and IVA-PLA2-
knockout mice.
PGE2 (ng/ml)
Wild-type mice (N) 4.2961.05
Wild-type mice (HF) 5.3261.17
KO mice (N) 0.5260.08
a
KO mice (HF) 0.8860.41
b
Wild-type and IVA-PLA2-knockout (KO) mice were fed normal (N) or high-fat
(HF) diets for 16 weeks and fasted. The serum levels of PGE2 were measured
(n=3–5).
aP,0.05 versus wild-type mice fed normal diets.
bP,0.05 versus wild-type mice fed HF diets.
doi:10.1371/journal.pone.0008089.t002
Figure 4. Microscopic views of epididymal fat pads in wild-type
and IVA-PLA2-knockout mice. Wild-type and IVA-PLA2-knockout (KO)
mice were fed normal or high-fat (HF) diets for 8 weeks and fasted.
Representativeepididymal fat pad sections stained withhematoxylin-eosin
are shown. Original magnification,64. IVA-PLA2 deficiency suppressed the
expansion of epididymal adipocytes induced by HF feeding.
doi:10.1371/journal.pone.0008089.g004
PLA2-Mediated Fatty Liver
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hepatic fat deposition is mediated in part by the direct deposition of
dietary fats, as in the case of adipose tissues, in wild-type mice. Our
recent [2] and the present studies showed that hepatic TG content
was lower in IVA-PLA2-knockout mice than in wild-type mice
under normal dietary conditions, suggesting a physiological role of
IVA-PLA2 in the regulation of TG accumulation in the liver.
Furthermore, HF diet-induced increase in hepatic TG content was
partially suppressed in IVA-PLA2-knockout mice compared with
wild-type mice, the reduced level being almost at the level observed
in wild-type mice fed normal diets. It is, consequently, possible that
since IVA-PLA2 is physiologically involved in the regulation of TG
content in the liver, a lack of IVA-PLA2 somewhat prevents hepatic
TG deposition even caused by excess dietary fat intake, thereby
resulting in the alleviation of large hepatic vacuolation. It has been
suggested thatPGE2playsa roleinhepatocellularTGaccumulation
[3,4]. In IVA-PLA2-knockout mice, serum PGE2 levels were indeed
reduced. However, other IVA-PLA2 metabolites, such as other
eicosanoids and lysophospholipids, are also probably reduced in
IVA-PLA2-knockout mice. Therefore, IVA-PLA2 metabolites
responsible for the accumulation of hepatic TG are unclear at
present. Meanwhile, a recent study showed that an HF diet-induced
increase in the mass of visceral adipose tissues precedes the
development of fatty liver accompanied with no significant change
in the serum levels of FFA, TG, or adiponectin in moderately obese
mice[16].Furthermore,fattyliverhasbeen shown tooccurthrough
adipose accumulation with adipocyte hypertrophy and slightly
decreased serum adiponectin levels, but without impaired glucose
tolerance or any change in the serum levels of FFA, TG, glucose,
insulin, or leptin in mice with an adipose-specific STAT3 (signal
transducer and activator of transcription 3) disruption resulting in
leptin resistance in adipocytes, even under normal dietary
conditions [17]. This observation suggests that adipose accumula-
tion and/or lower circulating adiponectin levels can cause the
development of fatty liver in the absence of high dietary fats and
metabolic disorders. Taking these findings and the notion
mentioned above into account, the present results also suggest that
theprotectionagainstthedevelopmentoffattyliverdamage inIVA-
PLA2-knockout mice fed HF diets may be ascribable, in part, to the
tendency towards a decreased adipose tissue mass with smaller
adipocytes. However, to clarify the precise roles of IVA-PLA2 in the
liver and adipose tissues, further studies with liver- or adipose-
specific IVA-PLA2-knockout mice are needed.
Regarding the role of PGs in an increase in adipose tissue mass,
PGE2 accelerates the deposition of intracellular TG by suppressing
the production of cAMP that induces lipolysis through the
activation of hormone-sensitive lipase in human and rat adipocytes
[12]. Furthermore, 15-deoxy-PGJ2 endogenously generated in
mature 3T3-L1 adipocytes participates in the accumulation of TG
probably through the activation of peroxisome proliferator-
activated receptor-c [5]. These findings suggest roles for PGE2
and 15-deoxy-PGJ2 in the hypertrophy of mature adipocytes. In
addition, PGI2 and 15-deoxy-PGJ2 play roles in the differentiation
of preadipocytes into mature adipocytes resulting in adipocyte
hyperplasia [12,18]. In contrast, PGF2a inhibits preadipocyte
differentiation [19]. Thus, PGs exhibit various effects on
adipogenesis in vitro. A previous study demonstrated that the
differentiation of 3T3-L1 preadipocytes is inhibited by the
knockdown of group VIA PLA2 or group VIB PLA2, other
isozymes of intracellular PLA2 [20], suggesting the contribution of
the isozymes to the generation of PGs responsible for preadipocyte
differentiation. Recently, we reported that adipose tissue mass and
adipocyte size are reduced in IVA-PLA2-knockout mice fed
normal diets compared with wild-type mice [2], with similar
results being observed in the present study. Furthermore, we show
here that under the HF dietary conditions, IVA-PLA2-knockout
mice with lower serum levels of PGE2 had lower adipose tissue
mass and smaller adipocytes than wild-type mice, suggesting that
the lower adipose tissue mass in IVA-PLA2-knockout mice fed HF
diets probably results from the smaller adipocytes. Collectively,
Figure 6. Serum levels of adipokines in wild-type and IVA-
PLA2-knockout mice. Wild-type and IVA-PLA2-knockout (KO) mice
were fed normal (N) or high-fat (HF) diets for 8 weeks and fasted. The
serum levels of adiponectin (A), leptin (B), and resistin (C) were
measured (n=4–6). *P,0.05 versus wild-type mice fed normal diets,
**P,0.05 versus IVA-PLA2-knockout mice fed normal diets. No
significant differences in the serum levels of adipokines were detected
between the two genotypes.
doi:10.1371/journal.pone.0008089.g006
PLA2-Mediated Fatty Liver
PLoS ONE | www.plosone.org 6 December 2009 | Volume 4 | Issue 12 | e8089IVA-PLA2 may also be involved in adipose accumulation through
the generation of PGs responsible for adipocyte hypertrophy.
The development of NAFLD is associated with the lower
circulating levels of adiponectin [21], hepatic fat deposition being
presumably due, in part, to the decreased fat burning effects of
adiponectin in the liver. Consistent with this notion, a previous
study showed that the administration of adiponectin to obese ob/ob
mice, resulting in its higher concentration in serum, has beneficial
effects on fatty liver [22]. This suggests that adiponectin itself or
factors that regulate the production of adiponectin can be potent
therapeutic molecular targets for the prevention of fatty liver. As
inhibitory regulators of adiponectin production, PGD2, PGJ2, and
15-deoxy-PGJ2 are shown to suppress the expression of adipo-
nectin in 3T3-L1 adipocytes [23]. In contrast, the serum levels of
adiponectin decrease in lipocalin-type PGD synthase-knockout
mice [24], suggesting a contribution of PGD2 to the production of
adiponectin. Among the inhibitory and stimulatory effects of PGs,
the former may be involved in the decrease in adiponectin level
observed in obesity and NAFLD. In the present study, however,
there was no difference between serum adiponectin levels in wild-
type and IVA-PLA2-knockout mice, irrespective of the kind of
diet, although the deficient mice were resistant to the HF diet-
induced development of fatty liver damage. At present, the reasons
for the lack of change in serum adiponectin levels in IVA-PLA2-
knockout mice are unclear. Other PLA2 isozymes might be
involved in the generation of PGs responsible for regulating the
expression of adiponectin. Alternatively, a deficiency of IVA-PLA2
might result in decreases in the levels of both inhibitory and
stimulatory PGs on the production of adiponectin. Meanwhile, the
serum levels of leptin correlate positively with adipose accumula-
tion [25]. Consistent with this, we show here that HF diets
increased the serum levels of leptin with adipose accumulation in
wild-type and IVA-PLA2-knockout mice. However, a deficiency of
IVA-PLA2 did not affect the HF diet-induced increase in serum
leptin levels. Considering the beneficial effects of leptin on fatty
liver [26,27], the changes in serum leptin levels under the HF
dietary conditions probably do not explain the reduced fatty liver
damage in IVA-PLA2-knockout mice. Previous studies showed
that the expression of leptin is inhibited by PGD2, PGJ2, and 15-
deoxy-PGJ2 in 3T3-L1 adipocytes [23], but stimulated by PGE2 in
mouse adipose tissues in primary culture [28]. As in the case of
adiponectin mentioned above, the possible involvement of IVA-
PLA2 in the generation of PGs that regulate the production of
leptin is unclear at present. To further clarify the role of IVA-PLA2
in the expression of adiponectin and leptin in adipocytes and
colocalized inflammatory cells, experiments with preadipocytes
and macrophages derived from IVA-PLA2-knockout mice are
underway in our laboratory.
Resistin has been implicated in the pathogenesis of obesity-
mediated insulin resistance [15]. Increased serum levels of resistin
are related to the histological severity of NAFLD in human
subjects [29]. A previous study demonstrated that hepatic TG
content tended to be lower in resistin-deficient mice [30]. These
findings suggest that higher serum levels of resistin are a cause of
the development of fatty liver. In the present study, no significant
difference was observed in the serum levels of resistin in wild-type
and IVA-PLA2-knockout mice. This observation is consistent with
the lack of changes in the serum levels of insulin and glucose in
both genotypes under the HF dietary conditions. Under our
experimental conditions, fatty liver damage in wild-type mice
probably develops in the absence of insulin resistance.
In summary, the present study demonstrates that a deficiency of
IVA-PLA2 protected mice against the HF diet-induced develop-
ment of fatty liver damage with adipose accumulation. The
alleviation of fatty liver damage is probably associated with the
decreased generation of IVA-PLA2 metabolites including PGs. To
our knowledge, this is the first report to suggest the possible
involvement of IVA-PLA2 in hepatic fat deposition progressing to
NAFLD under HF dietary conditions.
Materials and Methods
Mice
Homozygous IVA-PLA2-knockout mice with a C57BL/6
background (more than N19 generations) were generated by the
cross breeding of heterozygous IVA-PLA2-knockout mice, which
were a generous gift from Dr. T. Shimizu and Dr. N. Uozumi
(Department of Biochemistry and Molecular Biology, the
University of Tokyo) [31]. Male IVA-PLA2-knockout and wild-
type mice (6 weeks of age) were kept under a 12 h light/dark cycle,
and given normal (5.3% fat) or HF (D12108: 20% fat and 1.25%
cholesterol, Research Diets Inc.) diets for 8 or 16 weeks. For
measurement of food consumption, mice were housed individually
in cages with wire-screen floors and no bedding. Preweighed food
was placed in food cups attached to the cage floor with spring
clips. Food intake was then measured daily for 3 days before the
end of HF feeding period by weighting the food with careful
monitoring of any spillage. This study was approved by the
Experimental Animal Research Committee at Kyoto Pharmaceu-
tical University.
Histological Analysis
The animals were fasted for 20 h, and body weights were
measured before the collection of the blood and tissues. Mice were
deeply anesthetized with pentobarbital (0.3 mg/g body weight,
intraperitoneal administration). After the blood was collected from
the inferior vena cava, mice were perfused transcardially with
saline using a peristaltic pump. The liver and epidermal fat pads
were isolated and weighed. The isolated tissues were fixed in 10%
buffered formaldehyde and embedded in a paraffin block for
microtome slicing into 4-mm thick sections. The tissue sections
were deparaffinized and stained with hematoxylin-eosin or
periodic acid-Schiff. The stained sections were photographed
using a microscope (model IX71, Olympus, Tokyo, Japan) with a
digital camera.
Measurement of Biochemical Parameters and Analysis of
Lipoproteins in Serum
Collected blood samples from the inferior vena cava were
placed for 30 min at room temperature, and the supernatants
were obtained as serum after centrifugation. The serum levels of
TG, glucose, ALT, and AST were measured with an automatic
analyzer (DRI-CHEM 7000, Fujifilm Medical, Tokyo, Japan).
The serum levels of FFA, phospholipids, lysophosphatidylcholine,
insulin, adiponectin, leptin, and resistin were quantified with
commercial assay kits (Wako Pure Chemical Industries, Osaka,
Japan; Sceti Medical Labo K.K., Tokyo, Japan; R&D Systems,
Inc., Minneapolis, MN). For the determination of the serum levels
of PGE2, the serum from mice were collected and treated with
indomethacin (10 mg/ml). PGE2 was extracted from the samples
by solid phase extraction on a C18 cartridge. The concentrations
of PGE2 were analyzed with a commercial ELISA kit (R&D
Systems, Inc.) according to the manufacturer’s instructions.
Lipoproteins in the serum were analyzed with a liquid chroma-
tography system equipped with a reactor for a postcolumn
reaction to automatically measure the total amounts of cholesterol
of separated lipoproteins.
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The liver (100 mg wet tissue) was homogenized in an ice-cold
0.05% butylhydroxytoluene solution. After lipids were extracted
from the liver according to the method of Folch et al. [32] with a
slight modification, TG content in each sample was measured with
a commercial assay kit (Wako Pure Chemical Industries, Osaka,
Japan).
Statistical Analysis
Values are expressed as the mean 6 SEM. Data were analyzed
with Student’s t-test. P,0.05 was considered statistically
significant.
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